THROMBOXANE-B2 IN CARDIAC LYMPH - EFFECT OF SUPEROXIDE-DISMUTASE AND CATALASE DURING MYOCARDIAL-ISCHEMIA AND REPERFUSION

被引:17
作者
MICHAEL, LH
ZHANG, Z
HARTLEY, CJ
BOLLI, R
TAYLOR, AA
ENTMAN, ML
机构
[1] BAYLOR UNIV,DEPT MED,CARDIOL SECT,HOUSTON,TX 77030
[2] BAYLOR UNIV,DEPT MED,EXPTL THERAPEUT SECT,HOUSTON,TX 77030
[3] BAYLOR UNIV,DEBAKEY HEART CTR,HOUSTON,TX 77030
[4] METHODIST HOSP,HOUSTON,TX 77030
关键词
cardiac lymph; free radical scavengers; myocardial ischemia; myocardial reperfusion; thromboxane B[!sub]2[!/sub;
D O I
10.1161/01.RES.66.4.1040
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neutrophils have been implicated in the genesis of myocardial ischemia-reperfusion injury, and their mechanism of action has been linked to the production of reactive oxygen species, fatty acid-derived prostanoids, and leukotrienes. In this study, we examined the potential relation between production of reactive oxygen species and cyclooxygenase-derived autacoids by studying the effects of superoxide dismutase (SOD) and catalase (CAT) on the rise in thromboxane formation observed with myocardial ischemia and reperfusion. Immunoreactive thromboxane B2 was measured in cardiac lymph from conscious dogs during reperfusion after a 60-minute occlusion in the presence of infusions of SOD alone, CAT alone, and a combination of SOD and CAT. Reperfusion after 60 minutes of ischemia causes an immediate elevation in thromboxane B2. SOD and CAT infusion prevented this rise in thromboxane B2 as did infusion of SOD alone. The ability of SOD-CAT to suppress thromboxane B2 production dissipated within 3 hours after the cessation of infusion, at which time thromboxane B2 excretion increased. The modulation of fatty acid oxygenases by reactive oxygen species may be a very important pathogenic factor in considering the origin of the protective effect of antioxidants in the setting of myocardial ischemia-reperfusion injury.
引用
收藏
页码:1040 / 1044
页数:5
相关论文
共 21 条
[11]   MYOCARDIAL-ISCHEMIA - PLATELET AND THROMBOXANE CONCENTRATIONS IN CARDIAC LYMPH AND THE EFFECTS OF IBUPROFEN AND PROSTACYCLIN [J].
MICHAEL, LH ;
HUNT, JR ;
LEWIS, RM ;
ENTMAN, ML .
CIRCULATION RESEARCH, 1986, 59 (01) :49-55
[12]  
MONCADA S, 1984, NEW ENGL J MED, V300, P1141
[13]  
MULLANE KM, 1987, FASEB J, V46, P2422
[14]   ENHANCEMENT OF RECOVERY OF MYOCARDIAL-FUNCTION BY OXYGEN FREE-RADICAL SCAVENGERS AFTER REVERSIBLE REGIONAL ISCHEMIA [J].
MYERS, ML ;
BOLLI, R ;
LEKICH, RF ;
HARTLEY, CJ ;
ROBERTS, R .
CIRCULATION, 1985, 72 (04) :915-921
[15]  
ROY RS, 1983, OXYRADICALS THEIR SC, P12
[16]  
SCHMITZ JM, 1985, CIRC RES, V57, P223, DOI 10.1161/01.RES.57.2.223
[17]  
SHAPPELL S, 1987, PHARMACOLOGIST, V29, pA212
[18]  
SIEDLIK RH, 1985, METHOD ENZYMOL, V105, P412
[19]  
SIMPSON P, 1988, 1987 P UPJ S AUG, P63
[20]   IDENTIFICATION OF A TIME WINDOW FOR THERAPY TO REDUCE EXPERIMENTAL CANINE MYOCARDIAL INJURY - SUPPRESSION OF NEUTROPHIL ACTIVATION DURING 72 HOURS OF REPERFUSION [J].
SIMPSON, PJ ;
FANTONE, JC ;
MICKELSON, JK ;
GALLAGHER, KP ;
LUCCHESI, BR .
CIRCULATION RESEARCH, 1988, 63 (06) :1070-1079